These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 28500555

  • 1. CYT-Rx20 inhibits ovarian cancer cells in vitro and in vivo through oxidative stress-induced DNA damage and cell apoptosis.
    Wang YY, Chen YK, Hu SC, Hsu YL, Tsai CH, Chi TC, Huang WL, Hsieh PW, Yuan SF.
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1129-1140. PubMed ID: 28500555
    [Abstract] [Full Text] [Related]

  • 2. CYT-Rx20 Inhibits Cervical Cancer Cell Growth and Migration Through Oxidative Stress-Induced DNA Damage, Cell Apoptosis, and Epithelial-to-Mesenchymal Transition Inhibition.
    Wang YY, Hsieh PW, Chen YK, Hu SC, Hsu YL, Tsai CH, Yuan SF.
    Int J Gynecol Cancer; 2017 Sep; 27(7):1306-1317. PubMed ID: 30814237
    [Abstract] [Full Text] [Related]

  • 3. Synthetic β-nitrostyrene derivative CYT-Rx20 as inhibitor of oral cancer cell proliferation and tumor growth through glutathione suppression and reactive oxygen species induction.
    Wang YY, Chen YK, Hsu YL, Chiu WC, Tsai CH, Hu SC, Hsieh PW, Yuan SF.
    Head Neck; 2017 Jun; 39(6):1055-1064. PubMed ID: 28346709
    [Abstract] [Full Text] [Related]

  • 4. 3'-hydroxy-4'-methoxy-β-methyl-β-nitrostyrene inhibits tumorigenesis in colorectal cancer cells through ROS-mediated DNA damage and mitochondrial dysfunction.
    Tsai CH, Hung AC, Chen YY, Chiu YW, Hsieh PW, Lee YC, Su YH, Chang PC, Hu SC, Yuan SF.
    Oncotarget; 2017 Mar 14; 8(11):18106-18117. PubMed ID: 28178649
    [Abstract] [Full Text] [Related]

  • 5. The synthetic β-nitrostyrene derivative CYT-Rx20 induces breast cancer cell death and autophagy via ROS-mediated MEK/ERK pathway.
    Hung AC, Tsai CH, Hou MF, Chang WL, Wang CH, Lee YC, Ko A, Hu SC, Chang FR, Hsieh PW, Yuan SS.
    Cancer Lett; 2016 Feb 28; 371(2):251-61. PubMed ID: 26683774
    [Abstract] [Full Text] [Related]

  • 6. The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways.
    Chiu WC, Lee YC, Su YH, Wang YY, Tsai CH, Hou YA, Wang CH, Huang YF, Huang CJ, Chou SH, Hsieh PW, Yuan SF.
    PLoS One; 2016 Feb 28; 11(11):e0166453. PubMed ID: 27875549
    [Abstract] [Full Text] [Related]

  • 7. 3'-Hydroxy-4'-methoxy-β-methyl-β-nitrostyrene inhibits tumor growth through ROS generation and GSH depletion in lung cancer cells.
    Tsai CH, Hsieh PW, Lee YC, Wang CH, Chiu WC, Lu CW, Wang YY, Hu SC, Cheng TL, Yuan SF.
    Life Sci; 2017 Mar 01; 172():19-26. PubMed ID: 28007499
    [Abstract] [Full Text] [Related]

  • 8. Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer.
    Li N, Sun C, Zhou B, Xing H, Ma D, Chen G, Weng D.
    PLoS One; 2014 Mar 01; 9(7):e100314. PubMed ID: 24999622
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.
    Qin Y, Iwase A, Murase T, Bayasula, Ishida C, Kato N, Nakamura T, Osuka S, Takikawa S, Goto M, Kotani T, Kikkawa F.
    Reprod Biol Endocrinol; 2018 Oct 27; 16(1):106. PubMed ID: 30368246
    [Abstract] [Full Text] [Related]

  • 12. Discovery and Characterization of 4-Hydroxy-2-pyridone Derivative Sambutoxin as a Potent and Promising Anticancer Drug Candidate: Activity and Molecular Mechanism.
    Li LN, Wang L, Cheng YN, Cao ZQ, Zhang XK, Guo XL.
    Mol Pharm; 2018 Nov 05; 15(11):4898-4911. PubMed ID: 30223653
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI, Kim JH, Lee KT, Choi JH.
    Gynecol Oncol; 2011 Dec 05; 123(3):588-96. PubMed ID: 21945308
    [Abstract] [Full Text] [Related]

  • 16. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
    Saed GM, Fletcher NM, Diamond MP, Morris RT, Gomez-Lopez N, Memaj I.
    Gynecol Oncol; 2018 Mar 05; 148(3):567-575. PubMed ID: 29329880
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
    Zhang H, Jiao Y, Shi C, Song X, Chang Y, Ren Y, Shi X.
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun 01; 50(6):532-539. PubMed ID: 29701777
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis in ovarian cancer cells.
    Dong D, Dong Y, Fu J, Lu S, Yuan C, Xia M, Sun L.
    Life Sci; 2020 Aug 15; 255():117846. PubMed ID: 32470451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.